N Engl J Med. 2009 Feb 12;360(7):724-5. doi: 10.1056/NEJMe0810248.

Not an HIV cure, but encouraging new directions.

Levy JA.

Comment on

Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. [N Engl J Med. 2009]
Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.Hütter G, Nowak D, Mossner M, Ganepola S, Müssig A, Allers K, Schneider T, Hofmann J, Kücherer C, Blau O, et al. N Engl J Med. 2009 Feb 12; 360(7):692-8.

PMID:: 19213687; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

HIV/AIDS - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. [N Engl J Med. 2009]
Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.
Hütter G, Nowak D, Mossner M, Ganepola S, Müssig A, Allers K, Schneider T, Hofmann J, Kücherer C, Blau O, et al. N Engl J Med. 2009 Feb 12; 360(7):692-8.
Seeking a cure for AIDS. [AIDS Read. 2008]
Seeking a cure for AIDS.
Laurence J. AIDS Read. 2008 May; 18(5):228, 234.
Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy. [AIDS Res Hum Retroviruses. 2001]
Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy.
Bai J, Rossi J, Akkina R. AIDS Res Hum Retroviruses. 2001 Mar 20; 17(5):385-99.
Review CCR5 as target for HIV-1 gene therapy. [Curr Gene Ther. 2008]
Review CCR5 as target for HIV-1 gene therapy.
Nazari R, Joshi S. Curr Gene Ther. 2008 Aug; 8(4):264-72.
Review Maraviroc, a CCR5 coreceptor antagonist that blocks entry of human immunodeficiency virus type 1. [Pharmacotherapy. 2009]
Review Maraviroc, a CCR5 coreceptor antagonist that blocks entry of human immunodeficiency virus type 1.
Hunt JS, Romanelli F. Pharmacotherapy. 2009 Mar; 29(3):295-304.

See reviews... See all...

Cited by 1 PubMed Central article

Review Achieving a cure for HIV infection: do we have reasons to be optimistic? [J Antimicrob Chemother. 2012]
Review Achieving a cure for HIV infection: do we have reasons to be optimistic?
Le Douce V, Janossy A, Hallay H, Ali S, Riclet R, Rohr O, Schwartz C. J Antimicrob Chemother. 2012 May; 67(5):1063-74. Epub 2012 Feb 1.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Not an HIV cure, but encouraging new directions.
Not an HIV cure, but encouraging new directions.
N Engl J Med. 2009 Feb 12 ;360(7):724-5. doi: 10.1056/NEJMe0810248.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Not an HIV cure, but encouraging new directions.

Comment on

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information